Gulf International Bank (UK)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Buy
438,730
+156,327
+55% +$4.16M 0.28% 63
2025
Q4
$7.03M Buy
282,403
+220
+0.1% +$5.55K 0.23% 81
2025
Q3
$7.19M Sell
282,183
-5,459
-2% -$135K 0.24% 81
2025
Q2
$6.97M Sell
287,642
-37,395
-12% -$872K 0.25% 76
2025
Q1
$8.24M Sell
325,037
-111,144
-25% -$2.91M 0.28% 64
2024
Q4
$11.6M Sell
436,181
-4,782
-1% -$130K 0.29% 62
2024
Q3
$12.8M Sell
440,963
-19,507
-4% -$569K 0.33% 56
2024
Q2
$12.9M Sell
460,470
-35,515
-7% -$978K 0.32% 54
2024
Q1
$13.8M Buy
495,985
+2,315
+0.5% +$64.2K 0.35% 51
2023
Q4
$14.2M Sell
493,670
-41,918
-8% -$1.27M 0.4% 44
2023
Q3
$17.8M Sell
535,588
-59,379
-10% -$2.1M 0.5% 33
2023
Q2
$21.8M Sell
594,967
-169,291
-22% -$6.59M 0.54% 32
2023
Q1
$31.2M Sell
764,258
-203,226
-21% -$8.78M 0.65% 26
2022
Q4
$49.6M Sell
967,484
-4,338
-0.4% -$208K 0.87% 18
2022
Q3
$42.5M Buy
971,822
+31,543
+3% +$1.53M 0.8% 19
2022
Q2
$47.9M Buy
940,279
+3,080
+0.3% +$157K 0.85% 18
2022
Q1
$48.5M Sell
937,199
-300
-0% -$15.6K 0.72% 20
2021
Q4
$55.4M Sell
937,499
-189,932
-17% -$9.41M 0.78% 16
2021
Q3
$48.5M Sell
1,127,431
-11,865
-1% -$526K 0.62% 26
2021
Q2
$44.6M Buy
1,139,296
+26,215
+2% +$1.02M 0.57% 28
2021
Q1
$40.3M Sell
1,113,081
-125,621
-10% -$4.46M 0.55% 32
2020
Q4
$45.6M Sell
1,238,702
-186,995
-13% -$6.86M 0.6% 30
2020
Q3
$49.6M Sell
1,425,697
-9,271
-0.6% -$325K 0.7% 27
2020
Q2
$44.5M Buy
1,434,968
+16,340
+1% +$555K 0.68% 28
2020
Q1
$43.9M Buy
1,418,628
+15,082
+1% +$514K 0.83% 20
2019
Q4
$52.2M Sell
1,403,546
-2,741
-0.2% -$97.6K 0.79% 26
2019
Q3
$47.9M Sell
1,406,287
-1,391
-0.1% -$50.6K 0.8% 27
2019
Q2
$57.9M Sell
1,407,678
-70,856
-5% -$2.81M 0.97% 16
2019
Q1
$59.6M Sell
1,478,534
-1,349
-0.1% -$54K 1.04% 14
2018
Q4
$61.3M Sell
1,479,883
-631,507
-30% -$26.2M 1.21% 11
2018
Q3
$88.3M Buy
2,111,390
+89,932
+4% +$3.46M 1.04% 13
2018
Q2
$69.6M Buy
2,021,458
+42,723
+2% +$1.46M 0.87% 19
2018
Q1
$66.6M Sell
1,978,735
-13,690
-0.7% -$471K 0.86% 18
2017
Q4
$68.5M Hold
1,992,425
0.87% 17
2017
Q3
$67.5M Buy
1,992,425
+32,042
+2% +$1.03M 0.91% 16
2017
Q2
$62.5M Sell
1,960,383
-29,453
-1% -$929K 0.89% 16
2017
Q1
$64.6M Buy
1,989,836
+30,671
+2% +$967K 0.94% 15
2016
Q4
$60.4M Buy
1,959,165
+2,425
+0.1% +$74K 0.93% 18
2016
Q3
$62.9M Sell
1,956,740
-4,427
-0.2% -$148K 1.02% 15
2016
Q2
$65.5M Buy
1,961,167
+3,162
+0.2% +$101K 1.1% 13
2016
Q1
$55.1M Buy
1,958,005
+24,705
+1% +$706K 0.93% 16
2015
Q4
$59.2M Buy
1,933,300
+45,691
+2% +$1.44M 1.03% 14
2015
Q3
$56.3M Buy
1,887,609
+19,889
+1% +$638K 1.06% 12
2015
Q2
$59.4M Sell
1,867,720
-50,758
-3% -$1.65M 1.03% 10
2015
Q1
$63.3M Buy
1,918,478
+1,875
+0.1% +$59.6K 1.13% 10
2014
Q4
$56.6M Buy
1,916,603
+25,612
+1% +$734K 1% 11
2014
Q3
$53.1M Buy
1,890,991
+1,054
+0.1% +$29.6K 0.98% 12
2014
Q2
$53.2M Sell
1,889,937
-23,458
-1% -$669K 0.98% 12
2014
Q1
$58.3M Sell
1,913,395
-21,467
-1% -$640K 1.14% 11
2013
Q4
$56.2M Buy
+1,934,862
New +$56.3M 1.12% 11

Other funds holding PFE

Gulf International Bank (UK)'s PFE Position: Q1 2026 in Review

Gulf International Bank (UK) increased its Pfizer (PFE) stake by 55% in Q1 2026, buying an estimated $4.16M and bringing the position to 438,730 shares worth $12.3M. The position accounts for 0.28% of the portfolio, ranked #63.

Gulf International Bank (UK) first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $88.3M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Gulf International Bank (UK) held 438,730 shares of Pfizer worth $12.3M as of Q1 2026.
  • Gulf International Bank (UK) bought 156,327 Pfizer shares in Q1 2026, an estimated $4.16M.
  • Pfizer made up 0.28% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #63 holding.
  • Gulf International Bank (UK) first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • Gulf International Bank (UK)'s Pfizer position peaked at $88.3M in Q3 2018.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.